Myelodysplastic syndromes (MDS) belong to the malignant diseases of the hematopoietic system that occur primarily in older ...

Myelodysplastic syndromes (MDS) are treated based on type and risk assessment, but traditional therapies may not work for everyone. Clinical trials offer a way to explore emerging treatments and ...

Dr. Shaal Patel, a board certified physician in hematology, oncology, and internal medicine, spoke with Healthline about how myelodysplastic syndromes (MDS) can benefit from supportive therapy, ...

Of 35 people who died during follow-up in a randomized trial of daily vitamin C, 24 had been taking placebo and 11 had been ...

Panelists share insight on therapeutic goals when treating patients with myelodysplastic syndromes. Bruce Feinberg, DO: Amer, when we’re initiating, whether it’s ESAs [erythropoietin-stimulating ...

A panel of experts discuss the complex nature of myelodysplastic syndromes and concurrent subclassifications. At the start, we’re going to lean heavily on Dr Zeidan because we want to have a good ...

Myelodysplastic syndrome (MDS) is independently associated with incident cardiovascular disease (CVD), according to a study published online Nov. 10 in the Canadian Journal of Cardiology. Hiroyuki ...

Physician scientists at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine have published a review in the Journal of the American Medical Association that ...

Successful Management of Neutropenic Sepsis Is Key to Better Survival of Patients With Blood Cancer in Sri Lanka: Real-World Data From the Resource-Limited Setting Myelodysplastic syndromes (MDS) ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...